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Abstract
Background and Purpose—Acute triggers for ischemic stroke, which may include infection, 
are understudied, as is whether background cardiovascular disease (CVD) risk modifies such 
triggering. We hypothesized that infection increases acute stroke risk, especially among those with 
low CVD risk.
Methods—Hospitalized strokes and infections were identified in the Atherosclerosis Risk in 
Communities (ARIC) cohort. A case-crossover design and conditional logistic regression were 
used to compare hospitalized infections among stroke patients (14, 30, 42, and 90 days before 
stroke) with corresponding control periods 1 year and 2 years prior. Background CVD risk was 
assessed at both visit 1 and the visit most proximal to stroke, with risk dichotomized at the 
median.
Results—A total of 1,008 adjudicated incident ischemic strokes were included. Compared to 
control periods, hospitalized infection was more common within 2 weeks before stroke (14 day 
odds ratio (OR) = 7.7 (2.1, 27.3)); the strength of association declined with increasing time in the 
exposure window before stroke (30 day OR = 5.7 (2.3, 14.3), 42 day OR = 4.5 (2.0, 10.2), and 90 
day OR = 3.6 (2.1, 6.5)). Stroke risk was higher among those with low compared with high CVD 
risk, with this interaction reaching statistical significance for some exposure periods.
Conclusions—These results support the hypothesis that hospitalized infection is a trigger of 
ischemic stroke, and may explain some cryptogenic strokes. Infection control efforts may prevent 
strokes. CVD preventive therapies may prevent strokes if used in the peri-infection period but 
clinical trials are needed.
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Introduction
Population-based cohort studies have identified many long-term risk factors for incident 
ischemic stroke that are both modifiable, like high blood pressure, elevated serum 
cholesterol, and smoking, and non-modifiable, like male sex, non-white race, family history, 
and greater age.1–3 Short term risk factors – or triggers – of acute ischemic stroke include 
hypertensive crisis4, alcohol abuse5, and may include acute infection.5 Herein, we explore 
the relationship between hospitalization with infection and short-term stroke risk. 
Identifying and understanding stroke triggers offers potential strategies for stroke prevention 
during periods of vulnerability.
Several case-control studies have reported an association between various measures of 
infection and ischemic stroke.6–12 Two studies used a case cross-over design to identify an 
association between hospitalization with infection and short-term risk of ischemic 
stroke.13,14 Additionally, these two studies suggested that stroke risk after acute infection is 
greater in those with fewer vascular risk factors.13,14 The authors hypothesized that acute 
triggers, such as infection, were less relevant in people with more vascular risk factors since 
they are already at elevated stroke risk.
While recognition of infection as a trigger of ischemic stroke is growing, previous studies 
were often small, lacked prospective data, and failed to properly account for potential 
confounding factors. Further, previous studies have considered effect modification by 
individual vascular risk factors but have not yet examined how the infection-stroke 
triggering association varies by overall CVD risk level.
We used the data collected in the long-running, prospective cohort Atherosclerosis Risk in 
Communities (ARIC) Study to study the association further. Based on the previous 
literature, we hypothesized that there is an association between hospitalization with infection 
and acute ischemic stroke risk, and that infection is a stronger stroke trigger among patients 
with low background CVD risk.
Methods
Study Population
The ARIC Study is a prospective population-based cohort study comprising 15,792 adults 
aged 45–64 years at recruitment in 1987–1989.15 Subsequent exams took place 1990–1992 
(visit 2), 1993–1995 (visit 3), 1996–1998 (visit 4), and 2011–2013 (visit 5). Cohort 
participants were selected from four U.S. communities: Forsyth County, North Carolina; 
Jackson, Mississippi; suburbs of Minneapolis, Minnesota; and Washington County, 
Maryland. A detailed discussion of ARIC study design and objectives is provided 
elsewhere.15
Study Design
A case-crossover study design was used in which all ARIC participants who suffered an 
ischemic stroke during follow-up (n=1,062) served as their own control. The case-crossover 
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design affords the ability to isolate exposures that vary over time within person and better 
control for potential confounding that might occur between people. The occurrence of 
hospitalization with infection at intervals of 14, 30, 42, and 90 days prior to the stroke date 
were compared with two preceding control periods (1 year and 2 years prior to stroke). A 
washout period between the stroke admission date and preceding hospitalization with 
infection discharge date was used to exclude infections that may have been diagnosed 
secondarily at a stroke hospitalization. Cases whose control periods occurred prior to ARIC 
study enrollment were excluded (n=54) leaving a study sample of n=1,008. The study design 
is summarized in Figure 1.
Stroke ascertainment
Incident ischemic strokes were ascertained from hospitalizations reported by annual contact 
with participants, cardiovascular disease discharge lists provided by local hospitals, and 
death certificates. Incident ischemic strokes were identified and classified as thrombotic or 
cardioembolic by a computer algorithm and physician review based on signs, symptoms, 
neuroimaging (CT/MRI), and other diagnostic reports, according to criteria adapted from the 
National Survey of Stroke. Details on quality assurance for ascertainment and classification 
of ischemic stroke events are published elsewhere.3 All definite and probable incident 
ischemic strokes between study enrollment and year end 2011 were included in the analysis.
Main independent variable: hospitalization with infection
The exposure of interest was hospitalization with infection up to 90 days before ischemic 
stroke for the case period and equivalent 90-day control periods exactly 1 and 2 years before 
the ischemic stroke. The admission date for hospitalization with stroke was considered the 
stroke date, while the discharge date for hospitalization with infection was considered the 
infection date. Infection was assessed using abstracted hospital record discharge ICD-9-CM 
codes. The following ICD-9 codes for infection adapted from methodology used by Elkind 
et al.13 were included:
Respiratory - 460–466,480–487
Urinary tract - 599.0, 595, 590
Skin and subcutaneous tissue - 680–686
Bacteremia - 790.7
Osteomyelitis - 730.0–730.2
Other Infectious Diseases - 001–134
Codes in any position were counted. A washout period was used to exclude infections that 
may have been diagnosed secondarily at a stroke hospitalization. Washout periods of both 2 
and 4 days between stroke admission date and preceding hospitalization with infection 
discharge date were used and compared.
Measurement of other covariates
Background CVD risk was measured using the ACC/AHA 10-year CVD risk score.16 The 
CVD risk score uses sex, age, race, total cholesterol, blood pressure, diabetes status, and 
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smoking status to estimate 10-year CVD risk based on pooled cohort data. Data on risk 
factors were obtained at baseline (visit 1) and again during follow-up visits. We compared 
CVD risk score ascertained at baseline with that assessed at the participant’s study visit prior 
to the first control period to examine any differences in the magnitude of the associations of 
interest.
Statistical Analysis
Potential confounders that are stable within an individual are controlled in the case-
crossover study design by having cases serve as their own controls, a type of individual 
matching. Confounding by overall health status related to age is possible since deteriorating 
health could be a common cause of both infection and stroke. As participants age and their 
health status decreases, their stroke risk and hospitalization with infection risk may increase 
suggesting potential positive confounding by health status.
To reduce potential confounding, only time periods proximal to stroke (1 and 2 years 
previous) were included. We further controlled for the total number of hospitalizations in the 
9 months preceding the start of each of the three exposure periods (case period and two 
control periods) to account for potential decline in overall health status.
The prevalence of hospitalization with infection 14, 30, 42, and 90-days prior to ischemic 
stroke was compared to the corresponding time periods exactly 1 and 2 years prior to the 
stroke. Conditional logistic regression was used to estimate odds ratios (OR) of stroke and 
95% confidence intervals (CIs) for each time period (14, 30, 42, and 90 days). Interactions 
between hospitalized infection and CVD 10-year risk score, modeled continuously, were 
tested by adding an interaction term to the conditional logistic regression models. ORs 
associated with hospitalized infection were also estimated after dichotomizing CVD risk 
score at the median (10.00% for visit 1 and 15.38% for most recent visit) for ease of 
interpretation. Finally, models stratified by ischemic stroke sub-type (thrombotic and 
cardioembolic) were considered to evaluate if the infection-stroke triggering effect differed 
by ischemic stroke sub-type. Ischemic stroke sub-type definitions previously published in 
the ARIC study literature were used.3 For all analyses, both crude models and models 
adjusted for the number of hospitalizations were evaluated and presented.
Results
Of the 15,792 ARIC participants, 4,964 (31.4%) had a least one hospitalization with 
infection during follow-up and 1,062 (6.7%) suffered an ischemic stroke. Of the 1,062 
strokes identified during the follow-up period, 54 were excluded because their control 
periods occurred prior to ARIC study enrollment, leaving a total of 1,008 strokes for 
analysis. Baseline (ARIC visit 1) characteristics are provided in Table 1 for both stroke 
participants and non-stroke participants (for comparison). The majority of the stroke 
participants were white (60%), they were equally split between males and females, and had 
an average age of 56 years at baseline. Of the 1,008 stroke participants, 37 had a 
hospitalization with infection during the preceding 90 days. Models constructed using a 4-
day washout period produced results similar to the models constructed using a 2-day 
washout and thus only models using a 2-day washout period are presented. As shown in 
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Table 2, hospitalized infection was more common in all case periods compared to equivalent 
control periods but the ORs decrease with elapsed time: 14 day OR (95% CI) = 7.7 (2.1, 
27.3), 30 day OR (95% CI) = 5.7 (2.3, 14.3), 42 day OR (95% CI) = 4.5 (2.0, 10.2), and 90 
day OR (95% CI) = 3.6 (2.1, 6.5). Controlling for the number of hospitalizations slightly 
attenuated the association between hospitalization with infection and stroke.
In all interaction models, the infection-stroke association was stronger in those with low 
background CVD risk compared to those with high background CVD risk (Table 3). These 
interactions were significant for CVD risk measured at visit 1 for the 30-day (OR High CVD 
Risk – 2.5 vs. OR Low CVD Risk – 28.0) and 42-day (OR High CVD Risk – 2.0 vs. OR 
Low CVD Risk – 14.0) periods, and borderline significant for CVD risk measured at the 
most recent visit for the 30-day (OR High CVD Risk – 3.5 vs. OR Low CVD Risk – 26.0) 
period.
Results from the analysis stratified by ischemic stroke sub-type are presented in Table 4. The 
infection-stroke association was stronger among thrombotic strokes for the 14-day period 
(OR thrombotic – 9.6 vs OR cardioembolic - 8.0) but stronger for cardioembolic strokes for 
the 30-day (OR thrombotic 3.1 vs. OR cardioembolic – 16.3), 42-day (OR thrombotic – 2.4 
vs. OR cardioembolic – 18.3), and 90-day (OR thrombotic – 2.4 vs. OR cardioembolic – 
9.9) periods. The differences between thrombotic and cardioembolic strokes did not reach 
statistical significance for any time periods.
Discussion
This case-crossover study within a population-based cohort demonstrated that ischemic 
stroke risk is higher after hospitalization with infection. Patients with infection had higher 
odds of stroke up to 90 days after the hospitalization with infection compared to equivalent 
control periods 1 and 2 years previous. This supports our hypothesis that hospitalized 
infection is associated with higher ischemic stroke risk. The association between 
hospitalization with infection and stroke was graded, such that stroke risk was highest in the 
exposure periods most proximal to the stroke event and decreased as the time window before 
stroke increased. These results corroborate previous work that found that infection may 
function as a stroke trigger and that the stoke risk varies by time since infection.13 We found 
some evidence that stroke risk following hospitalization with infection appears to be more 
prominent in those with low background CVD risk. This pattern of interaction is consistent 
with results reported by Elkind et al.,13 but corroboration with larger studies is needed. 
Though the infection-stroke association may be stronger for cardioembolic strokes, it is 
difficult to determine if infection is a stronger trigger for a particular stroke sub-type given 
the imprecise estimates and wide confidence intervals due to small cell sizes.
Previous investigators have suggested possible mechanisms by which infection can trigger 
CVD events. Corrales-Medina et al. posited mechanisms by which infection may trigger 
coronary events, including via inflammation, prothrombosis, increased biomechanical stress 
on coronary arteries, variations in the coronary arterial tone, disturbed hemodynamic 
homoeostasis, and altered myocardial metabolic balance.17 Considering stroke, specifically, 
Elkind et al. suggest that infection may trigger stroke events through hypercoagulability, 
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platelet activation, and impaired endothelial function.13 They further hypothesize that 
infection may contribute to dehydration and immobility which increase stroke risk.13 
Additional research on the mechanisms linking infection and stroke including considering 
infection and stroke triggering by infection and stroke sub-type is warranted.
Our study has a number of strengths, including a large sample size from a community 
cohort, a rigorous methodology to adjudicate ischemic strokes, and a cross-over design to 
control for potential confounding. It also has limitations. Like all case crossover studies, our 
study may suffer from survival bias since we did not consider infections in participants who 
did not have a stroke. Confounding by age is possible because as participants age their risk 
of both stroke and hospitalization with infection increase. To reduce potential confounding, 
only time periods proximal to stroke (1 and 2 years previous) were examined and the total 
number of hospitalizations was included in the adjusted models. Other confounders such as 
medication use that may vary between the exposure and control periods were not measured. 
Relatively few infections prior to stroke yielded OR estimates that were imprecise, with 
wide confidence intervals. Since we used the hospital admission as the stroke date, stroke 
dates for patients who do not seek immediate medical attention may be inaccurate, but we 
think that this is rare since most patients immediately seek care. We certainly are under-
ascertaining infections, especially minor ones, by including only hospitalizations with 
infections. This would most likely lead to non-differential misclassification of the exposure 
that would typically bias ORs towards the null.
Our study has a number of implications. Identification of hospitalization with infection as a 
stroke trigger may prompt more aggressive treatment with standard preventive strategies, 
including antiplatelet agents and statins, during and immediately following hospitalization 
with infection to reduce the increased risk of acute stroke. This time period immediately 
following infection is referred to as a “treatable moment”.13 While antibiotics have not been 
shown to prevent vascular events18–20, other infection control efforts, including evidence-
based vaccination, may be considered because of their ability to not only reduce infection 
but stroke also.21 Further, considering past infections may help clinicians identify causes of 
so-called cryptogenic strokes.
Conclusion
Ischemic stroke patients have higher odds of a hospitalization with infection up to 90 days 
prior to their stroke compared to equivalent control periods 1 and 2 years previous. Stroke 
risk following hospitalization with infection appears to be higher in those with low 
background CVD risk. There may be a role from primary prevention with anti-platelet 
therapy in the immediate aftermath of an infection, though clinical trials and cost-benefit 
analysis should be considered.
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Figure 1. 
Case-crossover study design employed to study stroke in relation to triggering by 
hospitalized infection, ARIC. Presence of hospitalized infection was assessed for each of the 
12 time periods, and case period was compared to control periods.
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Table 1
Baseline (Visit 1) Characteristics of ARIC Participants by Future Stroke Status, 1987–89
Baseline Characteristic Stroke Participants
(n=1,008)
Non-Stroke Participants
(n=14,730)
Age, years, mean ± SD
  Age at Stroke, years, mean ± SD
56.1 ± 5.5
69.4 ± 7.6
54.0 ± 5.7
Sex, Count (%)
  Male 506 (50.2) 8,185 (55.6)
  Female 502 (49.8) 6545 (44.4)
Race, Count (%)
  White 607 (60.2) 10,844 (73.6)
  Black 400 (39.7) 3,839 (26.1)
  Asian 1 (0.1) 33 (0.2)
Current Smoker, Count (%)
  No 679 (67.4%) 10,934 (74.3)
  Yes 328 (35.6) 3,781 (25.7)
Diabetes
  No 739 (74.4) 13,004 (89.1)
  Yes 254 (25.6) 1,594 (10.9)
Treatment for Hypertension
  No 540 (53.6) 10,386 (70.6)
  Yes 468 (46.4) 4,4336 (29.5)
Systolic Blood Pressure, mm Hg
mean ± SD
129.8 ± 21.2 120.7 ± 18.6
HDL cholesterol, mg/dL, mean ± SD 48.4 ± 16.0 51.8 ± 17.2
Total Cholesterol, mg/dL mean ± SD 220.6 ± 45.4 214.5 ± 41.7
CVD 10-year risk probability, mean ±
SD
0.12 ± 0.10 0.07 ± 0.07
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Table 2
Association of Recent Hospitalization with Infection and Risk of Ischemic Stroke
Infection
hospitalization
by interval
before stroke
Case (n) Control (n) Unadjusted
OR, 95% CI
Adjusted*
OR, 95%CI
14 Days
  No 996 2013
8.0 (2.3, 28) 7.7 (2.1, 27)
  Yes 12 3
30 Days
  No 988 2010
6.3 (2.5, 16) 5.7 (2.3, 14)
  Yes 20 6
42 Days
  No 987 2008
5.3 (2.3, 12) 4.5 (2.1, 10)
  Yes 21 8
90 Days
  No 971 1995
3.9 (2.2, 6.9) 3.6 (2.1, 6.5)
  Yes 37 21
*Adjusted for total number of hospitalizations
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Table 3
Association of Recent Hospitalization with Infection and Risk of Ischemic Stroke by Background CVD Risk 
Score
Crude OR, Stratified by CVD Risk Score at Visit 1
High CVD Risk*
(n = 489) OR (95% CI)
Low CVD Risk†
(n=490) OR (95% CI)
Interaction
P-Value‡
14-Day 5.0 (1.0, 26) 12.0 (1.4, 100) 0.10
30-Day 2.5 (0.7, 9.3) 28.0 (3.7, 213) 0.03
42-Day 2.0 (0.6, 6.9) 14.0 (3.2, 62) 0.04
90-Day 2.7 (1.1, 6.3) 5.3 (2.3, 12) 0.31
Crude OR, Stratified by CVD Risk Score at Recent Visit
High CVD Risk§
(n=489) OR (95% CI)
Low CVD Risk‖
(n=488) OR (95% CI)
Interaction
P-Value‡
14-Day 7.0 (1.5, 34) 10.0 (1.2, 86) 0.39
30-Day 3.5 (1.0, 12) 26.0 (3.4, 199) 0.07
42-Day 3.2 (1.0, 9.8) 13.0 (2.9, 58) 0.13
90-Day 3.3 (1.5, 7.6) 5.4 (2.3, 13) 0.20
Adjusted# OR, Stratified by CVD Risk Score at Visit 1
High CVD Risk* (n=489)
Adjusted# OR (95% CI)
Low CVD Risk† (n=490)
Adjusted# OR (95% CI)
Interaction
P-Value‡
14-Day 4.2 (0.8, 23) 12.6 (1.5, 105) 0.10
30-Day 1.7 (0.4, 6.9) 25.9 (3.4, 198) 0.01
42-Day 1.4 (0.4, 5.2) 13.0 (2.9, 57) 0.02
90-Day 2.5 (1.0, 5.9) 5.1 (2.2, 12) 0.29
Adjusted# OR, Stratified by CVD Risk Score at Recent Visit
High CVD Risk§ (n=489)
Adjusted# OR (95% CI)
Low CVD Risk‖ (n=488)
Adjusted# OR (95% CI)
Interaction
P-Value‡
14-Day 6.2 (1.3, 30) 10.6 (1.2, 91) 0.36
30-Day 3.5 (1.0, 12) 26.0 (3.4, 199) 0.07
42-Day 2.4 (0.8, 7.7) 12.0 (2.7, 53) 0.11
90-Day 3.0 (1.3, 7.0) 5.2 (2.2, 12.4) 0.20
*10-year CVD Risk ≥10.00%
†10-year CVD Risk < 10.00%
‡
P-value from model with continuous CVD risk score
§10-year CVD Risk ≥15.38%
‖10-year CVD Risk < 15.38% 
#Adjusted for total number of hospitalizations
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Table 4
Association of Recent Hospitalization with Infection and Risk of Ischemic Stroke by Ischemic Stroke Sub-
Type
Crude OR Stratified by Ischemic Stroke Sub-Type
Thrombotic Stroke (n=752)
OR (95% CI)
Cardioembolic Stroke (n=256)
OR, (95% CI)
14 Day 12.0 (1.4, 99.7) 8.0 (0.9, 71.6)
30 Day 4.4 (1.5, 12.7) 16.0 (2.0, 127.9)
42 Day 3.4 (1.4, 8.7) 18.0 (2.3, 142.1)
90 Day 2.7 (1.4, 5.2) 10.0 (2.9, 34.5)
Adjusted* OR Stratified by Ischemic Stroke Sub-Type
Thrombotic Stroke (n=752)
OR (95% CI)
Cardioembolic Stroke (n=256)
OR, (95% CI)
14 Day 9.6 (1.1, 81.4) 8.0 (2.0, 130.1)
30 Day 3.1 (1.0, 9.3) 16.3 (2.0, 130.1)
42 Day 2.4 (0.9, 6.4) 18.3 (2.3, 144.3)
90 Day 2.4 (1.2, 4.7) 9.9 (2.8, 34.2)
*Adjusted for total number of hospitalizations
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